It has been reported that E2F2 plays a carcinogenic role in liver cancer [10] and breast cancer [11], while in prostate cancer, E2F2 inhibits tumor cell proliferation by targeting micorRNA [35]. This evidence concerns the gene E2F2 and prostate carcinoma.